Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07618000
NA

PI-YSP-0111 Formulation on Human Gut Microbiota and Body Composition

Sponsor: Taipei Medical University

View on ClinicalTrials.gov

Summary

The expected outcome of this study is that continuous 8-week supplementation with the PI-YSP-0111 prebiotic formulation will exert beneficial effects on gut microbiota modulation and liver health.

Official title: Evaluation of the Effects of the PI-YSP-0111 Formulation on Human Gut Microbiota and Body Composition

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

140

Start Date

2026-04-08

Completion Date

2027-04-07

Last Updated

2026-06-01

Healthy Volunteers

Yes

Interventions

DIETARY_SUPPLEMENT

PI-YSP-0111 formulation (High-dose)

6 per day(Lactobacillus rhamnosus MB17, Lactobacillus plantarum MB-10, Grape Seed extract, Oligo, Wofberry Extract Powder, Maltose powder, Aerosil, Magnesium Stearate)

DIETARY_SUPPLEMENT

PI-YSP-0111 formulation (Low-dose)

4 per day(Lactobacillus rhamnosus MB17, Lactobacillus plantarum MB-10, Grape Seed extract, Oligo, Wofberry Extract Powder, Maltose powder, Aerosil, Magnesium Stearate)

DIETARY_SUPPLEMENT

Placebo group(High-dose)

6 per day(Maltose powder, Aerosil, Magnesium Stearate)

DIETARY_SUPPLEMENT

Placebo group(Low-dose)

4 per day(Maltose powder, Aerosil, Magnesium Stearate)

Locations (2)

Taipei Medical University

Taipei, Taiwan, Taiwan

Taipei Municipal WanFang Hospital(Managed by Taipei Medical University)

Taipei, Taiwan, Taiwan